INBX
Inhibrx Biosciences, Inc.
Price Chart
No historical data available
Latest Quote
$123.41
-0.52 (-0.42%)
Current Price
| Previous Close | $123.93 |
| Open | $123.80 |
| Day High | $126.04 |
| Day Low | $119.38 |
| Volume | 241,480 |
Stock Information
| Shares Outstanding | 14.72M |
| Total Debt | $181.63M |
| Cash Equivalents | $133.34M |
| Net Income | $-138.18M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.82B |
| EPS (TTM) | $-8.88 |
| Exchange | NMS |
Recent Price History
No history data available. Data will be fetched automatically.
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on INBX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $1,300,000 | $200,000 | $1,800,000 | $1,301,000 |
| Operating Revenue | $1,300,000 | $200,000 | $1,800,000 | $1,301,000 |
| Expenses | ||||
| Interest Expense | $12,196,000 | $13,491,000 | $31,840,000 | - |
| Total Expenses | $136,325,000 | $331,648,000 | $221,021,000 | $116,624,000 |
| Other Income Expense | $-381,000 | $2,021,573,000 | $-580,000 | $1,000 |
| Other Non Operating Income Expenses | $-381,000 | $75,000 | $-580,000 | $1,000 |
| Net Non Operating Interest Income Expense | $-4,647,000 | $-2,551,000 | $-19,923,000 | - |
| Interest Expense Non Operating | $12,196,000 | $13,491,000 | $31,840,000 | - |
| Operating Expense | $136,325,000 | $331,648,000 | $221,021,000 | $116,624,000 |
| General And Administrative Expense | $23,118,000 | $127,501,000 | $29,381,000 | $15,035,000 |
| Other Operating Expenses | - | - | - | $-14,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-140,055,000 | $1,687,572,000 | $-241,361,000 | $-115,325,000 |
| Net Interest Income | $-4,647,000 | $-2,551,000 | $-19,923,000 | - |
| Interest Income | $7,549,000 | $10,940,000 | $11,917,000 | - |
| Normalized Income | $-140,055,000 | $-333,923,604 | $-241,361,000 | $-115,325,000 |
| Net Income From Continuing And Discontinued Operation | $-140,055,000 | $1,687,572,000 | $-241,361,000 | $-115,325,000 |
| Total Operating Income As Reported | $-135,025,000 | $-331,448,000 | $-219,221,000 | $-115,323,000 |
| Net Income Common Stockholders | $-140,055,000 | $1,687,572,000 | $-241,361,000 | $-115,325,000 |
| Net Income | $-140,055,000 | $1,687,572,000 | $-241,361,000 | $-115,325,000 |
| Net Income Including Noncontrolling Interests | $-140,055,000 | $1,687,572,000 | $-241,361,000 | $-115,325,000 |
| Net Income Continuous Operations | $-140,055,000 | $1,687,572,000 | $-241,361,000 | $-115,325,000 |
| Pretax Income | $-140,053,000 | $1,687,574,000 | $-239,724,000 | $-115,322,000 |
| Special Income Charges | $0 | $2,021,498,000 | $0 | - |
| Interest Income Non Operating | $7,549,000 | $10,940,000 | $11,917,000 | - |
| Operating Income | $-135,025,000 | $-331,448,000 | $-219,221,000 | $-115,323,000 |
| Depreciation Amortization Depletion Income Statement | $179,000 | $404,000 | - | - |
| Depreciation And Amortization In Income Statement | $179,000 | $404,000 | - | - |
| Earnings From Equity Interest Net Of Tax | - | $0 | $-1,634,000 | $0 |
| Per Share | ||||
| Diluted EPS | $-9.04 | $112.62 | $-16.95 | $-8.10 |
| Basic EPS | $-9.04 | $114.01 | $-16.95 | $-8.10 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $2,396 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-125,374,000 | $-318,148,000 | $-206,693,000 | $-114,098,000 |
| Total Unusual Items | $0 | $2,021,498,000 | $0 | - |
| Total Unusual Items Excluding Goodwill | $0 | $2,021,498,000 | $0 | - |
| Reconciled Depreciation | $2,483,000 | $2,285,000 | $1,191,000 | $1,225,000 |
| EBITDA (Bullshit earnings) | $-125,374,000 | $1,703,350,000 | $-206,693,000 | $-114,098,000 |
| EBIT | $-127,857,000 | $1,701,065,000 | $-207,884,000 | $-115,323,000 |
| Diluted Average Shares | $15,487,000 | $14,984,000 | $14,241,175 | $14,241,175 |
| Basic Average Shares | $15,487,000 | $14,802,000 | $14,241,175 | $14,241,175 |
| Diluted NI Availto Com Stockholders | $-140,055,000 | $1,687,572,000 | $-241,361,000 | $-115,325,000 |
| Tax Provision | $2,000 | $2,000 | $3,000 | $3,000 |
| Restructuring And Mergern Acquisition | $0 | $-2,021,498,000 | $0 | - |
| Research And Development | $113,028,000 | $203,743,000 | $191,640,000 | $101,603,000 |
| Selling General And Administration | $23,118,000 | $127,501,000 | $29,381,000 | $15,035,000 |
| Other Gand A | $23,118,000 | $127,501,000 | $29,381,000 | $15,035,000 |
Fetched: 2026-08-29
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $7,993,000 | $133,584,000 | $43,503,000 | $-7,300,000 |
| Total Assets | $146,478,000 | $180,767,000 | $307,893,000 | $16,645,000 |
| Total Non Current Assets | $13,646,000 | $20,369,000 | $12,535,000 | $10,382,000 |
| Other Non Current Assets | $4,378,000 | $6,831,000 | $3,164,000 | $3,164,000 |
| Current Assets | $132,832,000 | $160,398,000 | $295,358,000 | $6,263,000 |
| Other Current Assets | $1,541,000 | $1,198,000 | $1,094,000 | $674,000 |
| Prepaid Assets | $6,894,000 | $6,184,000 | $15,562,000 | $5,332,000 |
| Receivables | $177,000 | $420,000 | $778,000 | $257,000 |
| Other Receivables | $177,000 | $197,000 | - | - |
| Accounts Receivable | $0 | $200,000 | $778,000 | $243,000 |
| Cash Cash Equivalents And Short Term Investments | $124,220,000 | $152,596,000 | $277,924,000 | - |
| Cash And Cash Equivalents | $124,220,000 | $152,596,000 | $277,924,000 | - |
| Debt | ||||
| Total Debt | $107,012,000 | $8,048,000 | $210,141,000 | $5,033,000 |
| Long Term Debt And Capital Lease Obligation | $104,686,000 | $6,453,000 | $208,078,000 | $3,173,000 |
| Long Term Debt | $100,559,000 | - | $206,968,000 | - |
| Current Debt And Capital Lease Obligation | $2,326,000 | $1,595,000 | $2,063,000 | $1,860,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $138,485,000 | $47,183,000 | $264,390,000 | $23,945,000 |
| Total Non Current Liabilities Net Minority Interest | $104,686,000 | $6,453,000 | $208,078,000 | $3,173,000 |
| Current Liabilities | $33,799,000 | $40,730,000 | $56,312,000 | $20,772,000 |
| Payables And Accrued Expenses | $24,023,000 | $31,409,000 | $47,743,000 | $15,538,000 |
| Interest Payable | $857,000 | $0 | $2,348,000 | - |
| Payables | $5,944,000 | $9,245,000 | $10,954,000 | $4,343,000 |
| Accounts Payable | $5,944,000 | $9,245,000 | $10,954,000 | $4,343,000 |
| Equity | ||||
| Common Stock Equity | $7,993,000 | $133,584,000 | $43,503,000 | $-7,300,000 |
| Total Equity Gross Minority Interest | $7,993,000 | $133,584,000 | $43,503,000 | $-7,300,000 |
| Stockholders Equity | $7,993,000 | $133,584,000 | $43,503,000 | $-7,300,000 |
| Retained Earnings | $-246,187,000 | $-106,132,000 | $-613,734,000 | - |
| Other Equity Interest | - | - | $-7,973,000 | $-7,300,000 |
| Other | ||||
| Ordinary Shares Number | $14,577,609 | $14,475,904 | $14,241,175 | $14,241,175 |
| Share Issued | $14,577,609 | $14,475,904 | $14,241,175 | $14,241,175 |
| Tangible Book Value | $7,993,000 | $133,584,000 | $43,503,000 | $-7,300,000 |
| Invested Capital | $108,552,000 | $133,584,000 | $250,471,000 | $-7,300,000 |
| Working Capital | $99,033,000 | $119,668,000 | $239,046,000 | $-14,509,000 |
| Capital Lease Obligations | $6,453,000 | $8,048,000 | $3,173,000 | $5,033,000 |
| Total Capitalization | $108,552,000 | $133,584,000 | $250,471,000 | $-7,300,000 |
| Additional Paid In Capital | $254,179,000 | $239,715,000 | $657,232,000 | - |
| Capital Stock | $1,000 | $1,000 | $5,000 | - |
| Common Stock | $1,000 | $1,000 | $5,000 | - |
| Preferred Stock | $0 | $0 | $0 | - |
| Long Term Capital Lease Obligation | $4,127,000 | $6,453,000 | $1,110,000 | $3,173,000 |
| Current Capital Lease Obligation | $2,326,000 | $1,595,000 | $2,063,000 | $1,860,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $7,450,000 | $7,726,000 | $6,506,000 | $3,374,000 |
| Current Accrued Expenses | $18,079,000 | $22,164,000 | $36,789,000 | $11,195,000 |
| Net PPE | $9,268,000 | $13,538,000 | $9,371,000 | $7,218,000 |
| Accumulated Depreciation | $-11,121,000 | $-8,893,000 | $-6,687,000 | $-5,540,000 |
| Gross PPE | $20,389,000 | $22,431,000 | $16,058,000 | $12,758,000 |
| Leases | $795,000 | $795,000 | $441,000 | $441,000 |
| Other Properties | $5,535,000 | $7,338,000 | $2,952,000 | $4,717,000 |
| Machinery Furniture Equipment | $14,059,000 | $14,298,000 | $9,073,000 | $7,600,000 |
| Properties | $0 | $0 | $0 | $0 |
| Duefrom Related Parties Current | $0 | $23,000 | $0 | $14,000 |
| Construction In Progress | - | $0 | $3,592,000 | $0 |
Fetched: 2026-08-29
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-129,825,000 | $-197,006,000 | $-197,902,000 | $-91,497,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-129,794,000 | $-194,409,000 | $-193,309,000 | $-90,811,000 |
| Cash Flow From Continuing Operating Activities | $-129,794,000 | $-194,409,000 | $-193,309,000 | $-90,811,000 |
| Operating Gains Losses | $12,000 | $-1,998,797,000 | $1,637,000 | $19,000 |
| Investing Activities | ||||
| Capital Expenditure | $-31,000 | $-2,597,000 | $-4,593,000 | $-686,000 |
| Investing Cash Flow | $-28,000 | $-2,597,000 | $-4,593,000 | $-686,000 |
| Cash Flow From Continuing Investing Activities | $-28,000 | $-2,597,000 | $-4,593,000 | $-686,000 |
| Financing Activities | ||||
| Financing Cash Flow | $101,446,000 | $71,678,000 | $201,961,000 | $91,497,000 |
| Cash Flow From Continuing Financing Activities | $101,446,000 | $71,678,000 | $201,961,000 | $91,497,000 |
| Net Other Financing Charges | $-125,000 | - | $-355,000 | $91,497,000 |
| Issuance Of Capital Stock | - | $0 | $200,000,000 | - |
| Net Common Stock Issuance | - | $0 | $200,000,000 | - |
| Common Stock Issuance | - | $0 | $200,000,000 | - |
| Other | ||||
| Issuance Of Debt | $99,965,000 | $0 | - | - |
| Interest Paid Supplemental Data | $8,900,000 | $11,506,000 | $26,717,000 | - |
| Income Tax Paid Supplemental Data | $2,000 | $2,000 | $3,000 | $4,000 |
| End Cash Position | $124,220,000 | $152,596,000 | $277,924,000 | $0 |
| Beginning Cash Position | $152,596,000 | $277,924,000 | $273,865,000 | $0 |
| Changes In Cash | $-28,376,000 | $-125,328,000 | $4,059,000 | - |
| Proceeds From Stock Option Exercised | $1,606,000 | $71,678,000 | $2,316,000 | - |
| Net Issuance Payments Of Debt | $99,965,000 | $0 | - | - |
| Net Long Term Debt Issuance | $99,965,000 | $0 | - | - |
| Long Term Debt Issuance | $99,965,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-28,000 | $-2,597,000 | $-4,593,000 | $-686,000 |
| Sale Of PPE | $3,000 | $0 | - | - |
| Purchase Of PPE | $-31,000 | $-2,597,000 | $-4,593,000 | $-686,000 |
| Change In Working Capital | $-7,614,000 | $52,051,000 | $15,348,000 | $3,858,000 |
| Change In Other Current Liabilities | $-1,595,000 | $-1,408,000 | $-1,860,000 | $-1,674,000 |
| Change In Other Current Assets | $0 | $-3,667,000 | $0 | $-1,317,000 |
| Change In Payables And Accrued Expense | $-7,662,000 | $53,786,000 | $28,180,000 | $6,923,000 |
| Change In Accrued Expense | $-4,361,000 | $35,883,000 | $26,071,000 | $7,301,000 |
| Change In Payable | $-3,301,000 | $17,903,000 | $2,109,000 | $-378,000 |
| Change In Account Payable | $-3,301,000 | $17,903,000 | $2,109,000 | $-378,000 |
| Change In Prepaid Assets | $1,400,000 | $2,982,000 | $-10,285,000 | $407,000 |
| Change In Receivables | $243,000 | $358,000 | $-521,000 | $621,000 |
| Changes In Account Receivables | $200,000 | $-185,000 | $-535,000 | $130,000 |
| Other Non Cash Items | $4,242,000 | $3,962,000 | $5,030,000 | $1,621,000 |
| Stock Based Compensation | $11,138,000 | $58,518,000 | $24,846,000 | $17,791,000 |
| Depreciation Amortization Depletion | $2,483,000 | $2,285,000 | $1,191,000 | $1,225,000 |
| Depreciation And Amortization | $2,483,000 | $2,285,000 | $1,191,000 | $1,225,000 |
| Gain Loss On Sale Of PPE | $12,000 | $12,000 | $3,000 | $19,000 |
| Gain Loss On Sale Of Business | $0 | $-1,998,809,000 | $0 | - |
| Net Income From Continuing Operations | $-140,055,000 | $1,687,572,000 | $-241,361,000 | $-115,325,000 |
| Earnings Losses From Equity Investments | - | $0 | $1,634,000 | $0 |
| Change In Other Working Capital | - | - | $-166,000 | $-1,102,000 |
Fetched: 2026-08-29